Furthermore, a relatively low frequency of the other two founder mutations, c.4034delA and c.68_69delAG in our region denotes heterogenity of BRCA1 alterations in Polish patients with ovarian cancer. The gene discussed is BRCA1; the disease is ovarian carcinoma.